ISPOR

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.

ISPOR Membership: Becoming an ISPOR member offers unique advantages in health economics and outcomes research (HEOR). Members gain valuable benefits, global networking opportunities, and platforms for advancing HEOR excellence, joining nearly 18,000 professionals across 100+ countries who are dedicated to improving healthcare decision making worldwide.  https://www.ispor.org/membership

HEOR Learning Lab™ is ISPOR’s on-demand educational resource, offering unlimited video content from conferences and events. Covering key topics like real-world evidence, digital health, AI, and health policy, it supports continuous learning for HEOR professionals and interested learners worldwide. https://www.ispor.org/welcome-HEOR-Learning-Lab

ISPOR VIDEOS

CONTACT INFORMATION

ISPOR—The Professional Society for Health Economics and Outcomes Research

505 Lawrence Square Blvd South

Lawrenceville, NJ 08648

UNITED STATES

Phone: (609) 691-8942

Contact: Michelle Rovner

NEWS

FEATURED ARTICLES

  • Emerging trends in HEOR reveal how AI, real‑world evidence, value‑based care, digital health, and evolving affordability pressures are reshaping global healthcare.

  • Policy shifts are reshaping PBM oversight, driving transparent drug‑pricing tools, and influencing global responses that affect affordability, access, and future pharma development.

  • See late‑2025 policy actions, including international pricing agreements, new payment models, and global regulatory changes, while previewing key themes expected to shape 2026 health policy.

  • Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.

  • The May/June 2025 issue of Value & Outcomes Spotlight explores the health economics and outcomes research (HEOR) and its contribution to research and treatment of Alzheimer’s disease.

  • The March/April 2025 issue of Value & Outcomes Spotlight explores the urgent global health crisis of accessibility and affordability, highlighting the nearly 2 billion individuals lacking essential medicines.

  • Real-world evidence (RWE) offers insights into the effectiveness of medical treatments in everyday settings, with various stakeholders utilize RWE to enhance healthcare.

  • This report outlines ten defining HEOR trends influencing global health decision-making.

  • Health Economics and Outcomes Research (HEOR) plays a vital role in guiding evidence-based decisions across the healthcare ecosystem.